BioNexus Gene Lab (BGLC) Interest Coverage Ratio (2021 - 2026)

BioNexus Gene Lab has disclosed Interest Coverage Ratio across 6 years of filings, most recently posting 69.64 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio rose 44.42% year-over-year to 69.64; the TTM figure through Jun 2026 stood at 151.43 (down 10.61% YoY), while the FY2025 annual figure was 151.73, down 103.88% from the prior year.
• Interest Coverage Ratio came in at 69.64 for Q2 2026 at BioNexus Gene Lab, up from 175.2 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 89.48 in Q2 2023 to a low of 593.69 in Q3 2023.
• Average Interest Coverage Ratio over 5 years is 87.81, with a median of 64.57 recorded in 2026.
• The largest YoY upside for Interest Coverage Ratio was 250.41% in 2023 against a maximum downside of 1986.25% in 2023.
• Over 5 years, Interest Coverage Ratio stood at 25.76 in 2022, then jumped by 139.17% to 61.62 in 2023, then slumped by 216.22% to 71.61 in 2024, then plunged by 340.78% to 315.66 in 2025, then surged by 77.94% to 69.64 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 69.64 in Q2 2026, 175.2 in Q1 2026, and 315.66 in Q4 2025.